Company Overview
Snapshot
Founded in April 2022 by Aryeh Taub and Hovav Dror, EyeContact Dx operates with 11–50 employees. The company is currently in the Pre-Funding stage, focusing on the development of its eye-tracking-based screener for early autism spectrum disorder detection.
Business overview
EyeContact Dx is a Health Tech & Life Sciences company developing software solutions for the early detection of autism spectrum disorders (ASD) in toddlers. Its core product is an eye-tracking-based screener designed for seamless integration into pediatric clinics, providing fast and reliable results. The company partners with healthcare providers to deliver advanced, accessible care solutions, operating within the Digital Medical Diagnostics sector and leveraging Artificial Intelligence and Software platforms.
Log in to access full profile ›Company Intelligence Q&A
- What is EyeContact Dx's primary focus?
- EyeContact Dx is focused on developing software that detects autism spectrum disorders (ASD) in toddlers, aiming to provide advanced and accessible solutions for early ASD care.
- What is the core technology behind EyeContact Dx's product?
- The company's first product is an eye-tracking-based screener designed for seamless integration and fast, reliable results in detecting autism spectrum disorders.
- When was EyeContact Dx founded?
- EyeContact Dx was founded in April 2022.
- Who are the founders of EyeContact Dx?
- EyeContact Dx was co-founded by Aryeh Taub and Hovav Dror.
- What is the current employee size of EyeContact Dx?
- EyeContact Dx currently has 11–50 employees.